TECH Signal 207
Butyrate from gut bacteria reprograms intestinal lining cells to sustain anti-inflammatory responses after treatment stops
↗
Northwestern Medicine researchers found that butyrate, a short-chain fatty acid produced when gut bacteria ferment dietary fiber, induces lasting epigenetic changes in intestinal epithelial cells that maintain elevated IL-10 production and protect against colitis even after butyrate exposure ends.
The study identifies a specific mechanism, epigenetic activation of Sat1 in intestinal epithelial cells and downstream secretion of N1-acetylspermidine, through which a dietary metabolite creates durable immune tolerance rather than transient suppression. Only one feed carried this story, so independent corroboration is absent. The mouse and human cell culture results suggest a pathway that could be relevant to inflammatory bowel disease, but clinical translation remains untested.
Written by elseif from the cluster below · every claim links back to a sourceThe three things worth knowing
Butyrate-treated mice maintained elevated IL-10 production in CD4+ T-cells and resisted chemically induced colitis two weeks after butyrate was withdrawn.
The protective effect persisted in germ-free mice, indicating it does not require ongoing microbial stimulation.
Butyrate induced sustained transcriptional and epigenetic activation of Sat1 in intestinal epithelial cells, with N1-acetylspermidine identified as a candidate immunoregulatory factor.
THE CLUSTER